Literature DB >> 14744864

SH2-containing inositol phosphatase 2 predominantly regulates Akt2, and not Akt1, phosphorylation at the plasma membrane in response to insulin in 3T3-L1 adipocytes.

Toshiyasu Sasaoka1, Tsutomu Wada, Kazuhito Fukui, Shihou Murakami, Hajime Ishihara, Ryo Suzuki, Kazuyuki Tobe, Takashi Kadowaki, Masashi Kobayashi.   

Abstract

SH2-containing inositol phosphatase 2 (SHIP2) is a physiologically important negative regulator of insulin signaling by hydrolyzing the phosphatidylinositol (PI) 3-kinase product PI 3,4,5-trisphosphate in the target tissues of insulin. Targeted disruption of the SHIP2 gene in mice resulted in increased insulin sensitivity without affecting biological systems other than insulin signaling. Therefore, we investigated the molecular mechanisms by which SHIP2 specifically regulates insulin-induced metabolic signaling in 3T3-L1 adipocytes. Insulin-induced phosphorylation of Akt, one of the molecules downstream of PI3-kinase, was inhibited by expression of wild-type SHIP2, whereas it was increased by expression of 5'-phosphatase-defective (DeltaIP) SHIP2 in whole cell lysates. The regulatory effect of SHIP2 was mainly seen in the plasma membrane (PM) and low density microsomes but not in the cytosol. In this regard, following insulin stimulation, a proportion of Akt2, and not Akt1, appeared to redistribute from the cytosol to the PM. Thus, insulin-induced phosphorylation of Akt2 at the PM was predominantly regulated by SHIP2, whereas the phosphorylation of Akt1 was only minimally affected. Interestingly, insulin also elicited a subcellular redistribution of both wild-type and DeltaIP-SHIP2 from the cytosol to the PM. The degree of this redistribution was inhibited in part by pretreatment with PI3-kinase inhibitor. Although the expression of a constitutively active form of PI3-kinase myr-p110 also elicited a subcellular redistribution of SHIP2 to the PM, expression of SHIP2 appeared to affect the myr-p110-induced phosphorylation, and not the translocation, of Akt2. Furthermore, insulin-induced phosphorylation of Akt was effectively regulated by SHIP2 in embryonic fibroblasts derived from knockout mice lacking either insulin receptor substrate-1 or insulin receptor substrate-2. These results indicate that insulin specifically stimulates the redistribution of SHIP2 from the cytosol to the PM independent of 5'-phosphatase activity, thereby regulating the insulin-induced translocation and phosphorylation of Akt2 at the PM.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14744864     DOI: 10.1074/jbc.M311534200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  Activating Akt and the brain's resources to drive cellular survival and prevent inflammatory injury.

Authors:  Z Z Chong; F Li; K Maiese
Journal:  Histol Histopathol       Date:  2005-01       Impact factor: 2.303

2.  Insulin-stimulated plasma membrane association and activation of Akt2, aPKC zeta and aPKC lambda in high fat fed rodent skeletal muscle.

Authors:  Henry J Herr; Jeffrey R Bernard; Donald W Reeder; Donato A Rivas; Jose J Limon; Ben B Yaspelkis
Journal:  J Physiol       Date:  2005-03-31       Impact factor: 5.182

3.  Insights into the PI3-K-PKB-mTOR signalling pathway from small molecules.

Authors:  Richard M Gunn; Helen C Hailes
Journal:  J Chem Biol       Date:  2008-07-15

4.  The inositol polyphosphate 5-phosphatase, PIPP, Is a novel regulator of phosphoinositide 3-kinase-dependent neurite elongation.

Authors:  Lisa M Ooms; Clare G Fedele; Megan V Astle; Ivan Ivetac; Vanessa Cheung; Richard B Pearson; Meredith J Layton; Ariel Forrai; Harshal H Nandurkar; Christina A Mitchell
Journal:  Mol Biol Cell       Date:  2005-11-09       Impact factor: 4.138

5.  Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes.

Authors:  Alain Veilleux; Vanessa P Houde; Kerstin Bellmann; André Marette
Journal:  Mol Endocrinol       Date:  2010-03-04

6.  Discovery and functional characterization of a novel small molecule inhibitor of the intracellular phosphatase, SHIP2.

Authors:  A Suwa; T Yamamoto; A Sawada; K Minoura; N Hosogai; A Tahara; T Kurama; T Shimokawa; I Aramori
Journal:  Br J Pharmacol       Date:  2009-08-19       Impact factor: 8.739

7.  Serum withdrawal-induced accumulation of phosphoinositide 3-kinase lipids in differentiating 3T3-L6 myoblasts: distinct roles for Ship2 and PTEN.

Authors:  Adel Mandl; Deborah Sarkes; Valerie Carricaburu; Vanessa Jung; Lucia Rameh
Journal:  Mol Cell Biol       Date:  2007-09-24       Impact factor: 4.272

8.  Interaction of the WD40 domain of a myoinositol polyphosphate 5-phosphatase with SnRK1 links inositol, sugar, and stress signaling.

Authors:  Elitsa A Ananieva; Glenda E Gillaspy; Amanda Ely; Ryan N Burnette; F Les Erickson
Journal:  Plant Physiol       Date:  2008-10-17       Impact factor: 8.340

Review 9.  Phosphoinositide phosphatases in cell biology and disease.

Authors:  Yang Liu; Vytas A Bankaitis
Journal:  Prog Lipid Res       Date:  2010-01-05       Impact factor: 16.195

Review 10.  Discovery and development of small molecule SHIP phosphatase modulators.

Authors:  William G Kerr; John D Chisholm; Dennis R Viernes; Lydia B Choi
Journal:  Med Res Rev       Date:  2013-12-02       Impact factor: 12.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.